Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Lymphoma Genomics

Clinical Trials

    • Cancer(5)
  • Lymphoma

    test

    • Pediatric Cancers

      A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma (RELATIVITY-069)

      • Lymphoma

        A Prospective, Observational, Long-term Follow-up Study for Subjects Who Previously Received Zamtocabtagene Autoleucel in a United States Miltenyi Biomedicine-Sponsored Clinical Study

        • Lymphoma

          Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma

          • Leukemia

            Phase II Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma

            • About Us
            • Contact Us
            • Donate
            • Referring Doctors
            • Clinical Keywords

            333 Cedar St.

            New Haven, CT 06510

            • Yale School of Medicine
            • Yale University
            • Terms & Privacy Policies
            • Accessibility at YSM
            • Patient Rights
            • HIPAA at Yale
            • Non-discrimination Statement
            Copyright 2025 Yale Medicine